Skip to main content

CBF2 Antibody [PerCP]

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-97347PCP

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-97347PCP

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

PerCP (Excitation = 490 nm, Emission = 675 nm)

Antibody Source

Polyclonal Rabbit IgG

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

Produced in rabbits immunized with E. coli-derived Human CBF2 fragment.

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Applications for CBF2 Antibody [PerCP]

Application
Recommended Usage

Western Blot

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Antigen and protein A Affinity-purified

Formulation

PBS

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: CBF2

Stimulates transcription from the HSP70 promoter

Alternate Names

CBF2CTF2, CBFHSP-CBF, CCAAT/enhancer binding protein (C/EBP), zeta, CCAAT/enhancer binding protein zeta, CCAAT/enhancer-binding protein zeta, CCAAT-binding factor, CCAAT-box-binding transcription factor, NOC1

Gene Symbol

CEBPZ

Additional CBF2 Products

Product Documents for CBF2 Antibody [PerCP]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for CBF2 Antibody [PerCP]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...